Page last updated: 2024-09-03
ici 169369 and azetirelin
ici 169369 has been researched along with azetirelin in 1 studies
Compound Research Comparison
| Studies (ici 169369) | Trials (ici 169369) | Recent Studies (post-2010) (ici 169369) | Studies (azetirelin) | Trials (azetirelin) | Recent Studies (post-2010) (azetirelin) |
|---|---|---|---|---|---|
| 31 | 4 | 0 | 47 | 0 | 0 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cools, AR; Kobayashi, M; Koshida, Y; Koshikawa, N; Miwa, Y; Miyata, N | 1 |
Other Studies
1 other study(ies) available for ici 169369 and azetirelin
| Article | Year |
|---|---|
YM-14673, a thyrotropin-releasing hormone analogue, injected into the nucleus accumbens and the striatum produces repetitive jaw movements in rats.
Topics: Animals; Azetidines; Behavior, Animal; Corpus Striatum; Dipeptides; Dose-Response Relationship, Drug; Electromyography; Flupenthixol; Injections, Spinal; Jaw; Male; Nucleus Accumbens; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin Antagonists; Thyrotropin-Releasing Hormone | 1995 |